Company Filing History:
1 out of 14 
1 out of 6 
Years Active: 2023
Title: Amel Garnaoui: Innovator in Leishmaniasis Research
Introduction
Amel Garnaoui is a notable inventor based in Tunis, Tunisia. He has made significant contributions to the field of medical research, particularly in the development of vaccines against leishmaniasis. His innovative work has the potential to impact public health positively.
Latest Patents
Amel Garnaoui holds 1 patent for his invention titled "Multi-epitopic peptide compounds and vaccines against leishmaniasis." This invention relates to multi-epitopic peptide compounds obtained from PSA, HwB, and LmLRAB proteins. It also includes pharmaceutical compositions and vaccines designed for use against one or more forms of leishmaniasis.
Career Highlights
Throughout his career, Amel has worked with esteemed institutions such as the Institut de Recherche pour le Développement and the Institut Pasteur de Tunis. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Amel has collaborated with notable colleagues, including Rachel Bras Gonçalves and Jean-Loup Lemesre. These partnerships have enriched his research and fostered a collaborative environment for innovation.
Conclusion
Amel Garnaoui's work in developing vaccines against leishmaniasis showcases his dedication to medical research and innovation. His contributions are vital in the fight against this disease, and his patent reflects his commitment to improving public health.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.